In the present study, we provide in vitro cellular and in vivo human tumor evidence to indicate that IL-10 mRNA expression levels may independently predict the survival and relapse rates in patients with HPV-positive OSCC, but not in those with HPV-negative OSCC. The gene discussed is IL10; the disease is neoplasm.